New treatments for common cardiovascular risk factor near the market, with billions at stake
My colleague @DrewQJoseph takes a look at the race to develop drugs targeting Lp(a) — $NVS $AMGN and $LLY
Show more
Register and share your invite link to earn from video plays and referrals.
